| Revenue by destination | |||
| 2025 | |||
| £’000 | |||
| 2024 | |||
| (restated) | |||
| 1 | |||
| £’000 | |||
| United Kingdom | 6,992 | 8,052 | |
| Rest of Europe | – Germany | 7,151 | 4,892 |
| – Ireland | 8,783 | 16,552 | |
| – Other | 15,759 | 14,095 | |
| The Americas | – USA | 52,962 | 57,412 |
| – Other | 7,415 | 14,555 | |
| Rest of the World | – China | 9,559 | 11, 4 9 5 |
| – Other | 23,853 | 23,150 | |
| 132,474 | 150,203 |
| Non-current assets by destination | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| United Kingdom | 45,560 | 45,698 |
| United States | 26,564 | 26,925 |
| China | 980 | 98 |
| 73,10 4 | 72,721 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| (restated) | ||
| 2 | ||
| £’000 | ||
| Depreciation of property, plant and equipment and right-of-use assets | 5,039 | 4,640 |
| Amortisation of intangible assets | 469 | 426 |
| Loss on disposal of property, plant and equipment | 72 | 28 |
| Loss on disposal of intangible assets | 80 | – |
| Research and development costs | 934 | 1,473 |
| Research and development tax credits | (124) | (45) |
| Net foreign exchange (gain)/expense | ||
| 3 | ||
| (488) | 717 | |
| Cost of inventories recognised as an expense | 85,576 | 91,358 |
| Write down of inventories recognised as an expense | 412 | 785 |
| Shipping costs | 2,704 | 2,888 |
| IT and telephony costs | 1,212 | 1,038 |
| Insurance costs | 1,187 | 1,255 |
| Energy and utility costs | 1,420 | 1,446 |
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Fees payable to the Parent Company’s auditors and their associates | ||
| for the audit of: | ||
| – the Parent Company and Group accounts | 131 | 116 |
| – the Group’s subsidiaries pursuant to legislation | 314 | 257 |
| Total audit fees | 445 | 373 |
| Fees payable to the Parent Company’s auditors and their associates | ||
| for other services to the Group: | ||
| – other assurance services | 3 | 18 |
| Total non-audit fees | 3 | 18 |
| Group | ||
| 2025 | ||
| Number | ||
| 2024 | ||
| Number | ||
| Technical and production | 156 | 161 |
| Administration and sales | 206 | 209 |
| 362 | 370 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Wages and salaries | 18,321 | 18,994 |
| Social security costs | 1,758 | 1,592 |
| Pension costs (see note 27) | 1,201 | 1,213 |
| Share-based payments (see note 26) | 292 | 512 |
| 21,572 | 22 , 311 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Directors in aggregate: | ||
| Emoluments in respect of qualifying services | 736 | 679 |
| Fees paid to Non-executive Directors in respect of qualifying services | 354 | 367 |
| Taxable benefits in respect of qualifying services | 31 | 20 |
| Share-based payments expense in respect of qualifying services | – | 69 |
| Pension contributions to money purchase schemes | 59 | 51 |
| 1,180 | 1,186 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Finance income | ||
| Other interest received | 3 | 5 |
| Post-employment benefit income (see note 27) | 287 | 224 |
| 290 | 229 | |
| Finance costs | ||
| Bank interest paid | 233 | 678 |
| Other bank finance costs | 399 | 314 |
| Lease liabilities finance expense (see note 14) | 12 | 13 |
| 644 | 1,005 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Treatt PLC acquisition: | ||
| Acquisition expenses | 2,374 | – |
| Less: tax effect of acquisition expenses | (92) | – |
| Regional restructuring: | ||
| Restructuring expenses | 538 | 328 |
| Less: tax effect of restructuring expenses | (135) | (82) |
| Other exceptionals: | ||
| Other exceptional expenses (see below) | 397 | – |
| Less: tax effect of other exceptional expenses | (49) | – |
| Relocation expenses: | ||
| Relocation expenses | – | 302 |
| Less: tax effect of relocation expenses | – | (20) |
| 3,033 | 528 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Current tax: | ||
| UK corporation tax on profits for the year | – | – |
| Adjustments to UK tax in respect of previous periods | 58 | – |
| Overseas corporation tax on profits for the year | 2,219 | 4,230 |
| Adjustments to overseas tax in respect of previous periods | 82 | 30 |
| Total current tax | 2,359 | 4,260 |
| Deferred tax: | ||
| Origination and reversal of temporary differences | (142) | (120) |
| Effect of change of tax rate on opening deferred tax | – | (77) |
| Adjustments in respect of previous periods | (278) | (1) |
| Total deferred tax (see note 22) | (420) | (198) |
| Tax on prot on ordinary activities | 1,939 | 4,062 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Current tax: | ||
| Foreign currency translation differences | 31 | – |
| Total current tax | 31 | – |
| Deferred tax: | ||
| Cash flow hedges | (27) | 49 |
| Foreign currency translation differences | (10) | 257 |
| Defined benefit pension scheme | (419) | 323 |
| Total deferred tax (see note 22) | (456) | 629 |
| Total tax (credit)/charge recognised in other comprehensive income | (425) | 629 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Deferred tax: | ||
| Share-based payments | – | 23 |
| Total tax charge recognised in equity | – | 23 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| (restated) | ||
| 1 | ||
| £’000 | ||
| Prot before tax multiplied by standard rate of UK corporation tax | ||
| at 25.0% (2024: 25.0%) | 1,751 | 4,480 |
| Effects of: | ||
| Prior period adjustment | ||
| 1 | ||
| tax impact | – | 136 |
| Expenses not deductible in determining taxable profit | 753 | 116 |
| Adjustments in respect of overseas state taxes | 273 | 309 |
| Benefits of overseas tax incentives | (229) | (320) |
| Research and development tax credits | (24) | (19) |
| Difference in tax rates on overseas earnings | (400) | (654) |
| Adjustments to tax charge in respect of prior years | (196) | 29 |
| Deferred tax not recognised | 11 | (15) |
| Total tax charge for the year | 1,939 | 4,062 |
| Dividend per share for years ended | |||||
| 30 September | |||||
| Parent Company and Group | |||||
| 2025 | |||||
| Pence | |||||
| 2024 | |||||
| Pence | |||||
| 2023 | |||||
| Pence | |||||
| 2025 | |||||
| £’000 | |||||
| 2024 | |||||
| £’000 | |||||
| Interim dividend | 2.60p | ||||
| 3 | |||||
| 2.60p | |||||
| 2 | |||||
| 2.55p | |||||
| 1 | |||||
| 1,593 | 1,589 | ||||
| Final dividend | 3.00p | ||||
| 4 | |||||
| 5.81p | |||||
| 3 | |||||
| 5.46p | |||||
| 2 | |||||
| 3,554 | 3,335 | ||||
| 5.60p | 8.41p | 8.01p | 5,147 | 4,924 |
| Group | 2025 | |
| 2024 | ||
| (restated) | ||
| 1 | ||
| Profit after taxation attributable to owners of the Parent Company (£’000) | 5,064 | 13,857 |
| Weighted average number of ordinary shares in issue (‘000) | 60,446 | 61,006 |
| Basic earnings per share (pence) | 8.38p | 22.71p |
| Group | ||
| 2025 | ||
| No. (‘000) | ||
| 2024 | ||
| (restated) | ||
| 1 | ||
| No. (‘000) | ||
| Weighted average number of shares | 61,265 | 61,210 |
| Weighted average number of shares held in the EBT | (59) | (204) |
| Weighted average number of shares held in treasury | (760) | – |
| Weighted average number of shares used for calculating basic EPS | 60,446 | 61,006 |
| Executive share option schemes | 117 | 269 |
| All-employee share options | 14 | 69 |
| Weighted average number of shares used for calculating diluted EPS | 60,577 | 61,344 |
| Diluted earnings per share (pence) | 8.36p | 22.59p |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| (restated) | ||
| 1 | ||
| £’000 | ||
| Profit after taxation attributable to owners of the Parent Company | 5,064 | 13,857 |
| Adjusted for: | ||
| Exceptional items – Treatt PLC acquisition (see note 8) | 2,374 | – |
| Exceptional items – regional restructuring (see note 8) | 538 | 328 |
| Exceptional items – relocation (see note 8) | – | 302 |
| Exceptional items – other (see note 8) | 397 | – |
| Taxation thereon | (276) | (102) |
| Adjusted earnings | 8,097 | 14,385 |
| Adjusted basic earnings per share (pence) | 13.40p | 23.58p |
| Adjusted diluted earnings per share (pence) | 13.37p | 23.45p |
| Group | |||
| Development | |||
| costs | |||
| £’000 | |||
| Software | |||
| licences | |||
| £’000 | |||
| Total | |||
| £’000 | |||
| Cost: | |||
| 1 October 2023 | 1,015 | 2,785 | 3,800 |
| Exchange adjustment | (41) | (12) | (53) |
| Additions | 114 | 129 | 243 |
| 30 September 2024 | 1,088 | 2,902 | 3,990 |
| Exchange adjustment | (2) | (1) | (3) |
| Additions | – | 245 | 245 |
| Disposals | (16) | (358) | (374) |
| 30 September 2025 | 1,070 | 2,788 | 3,858 |
| Amortisation: | |||
| 1 October 2023 | 367 | 681 | 1,048 |
| Exchange adjustment | (15) | (3) | (18) |
| Charge for year | 50 | 376 | 426 |
| 30 September 2024 | 402 | 1,054 | 1,456 |
| Exchange adjustment | (2) | (2) | (4) |
| Charge for year | 79 | 390 | 469 |
| Disposals | – | (294) | (294) |
| 30 September 2025 | 479 | 1,148 | 1,627 |
| Net book value: | |||
| 30 September 2025 | 591 | 1,640 | 2,231 |
| 30 September 2024 | 686 | 1,848 | 2,534 |
| Group | |||||
| Land and | |||||
| buildings | |||||
| £’000 | |||||
| Plant and | |||||
| machinery | |||||
| £’000 | |||||
| Fixtures, fittings | |||||
| and equipment | |||||
| £’000 | |||||
| Laboratory | |||||
| equipment | |||||
| £’000 | |||||
| Total | |||||
| £’000 | |||||
| Cost: | |||||
| 1 October 2023 | 36,574 | 39,667 | 7,166 | 2,313 | 85,720 |
| Exchange adjustment | (1,320) | (1,896) | (369) | (80) | (3,665) |
| Additions | – | 3,635 | 1,423 | 365 | 5,423 |
| Disposals | – | (61) | (218) | (23) | (302) |
| 30 September 2024 | 35,254 | 41,345 | 8,002 | 2,575 | 87,176 |
| Exchange adjustment | (54) | (91) | (44) | (9) | (198) |
| Additions | 5 | 2,107 | 2,398 | 463 | 4,973 |
| Disposals | – | (344) | (657) | (2) | (1,003) |
| Reclassification | – | (282) | 289 | (7) | – |
| Transfer from spares | – | 400 | – | – | 400 |
| 30 September 2025 | 35,205 | 43,135 | 9,988 | 3,020 | 91,348 |
| Depreciation: | |||||
| 1 October 2023 | 2,581 | 8,862 | 2,145 | 606 | 14,194 |
| Exchange adjustment | (204) | (715) | (105) | (40) | (1,064) |
| Charge for year | 596 | 2,736 | 828 | 315 | 4,475 |
| Disposals | – | (47) | (167) | (23) | (237) |
| 30 September 2024 | 2,973 | 10,836 | 2,701 | 858 | 17, 368 |
| Exchange adjustment | (15) | (63) | (8) | (6) | (92) |
| Charge for year | 588 | 2,880 | 998 | 352 | 4,818 |
| Disposals | – | (81) | (652) | (2) | (735) |
| 30 September 2025 | 3,546 | 13,572 | 3,039 | 1,202 | 21,359 |
| Net book value: | |||||
| 30 September 2025 | 31,659 | 29,563 | 6,949 | 1,818 | 69,989 |
| 30 September 2024 | 32,281 | 30,509 | 5,301 | 1,717 | 69,808 |
| Capital commitments | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Contracted but not provided for | 1,045 | 1,708 |
| Group | |||
| Land and | |||
| buildings | |||
| £’000 | |||
| Plant and | |||
| machinery | |||
| £’000 | |||
| Total | |||
| £’000 | |||
| Net carrying value: | |||
| 1 October 2023 | – | 538 | 538 |
| Exchange adjustment | – | (3) | (3) |
| Additions | – | 9 | 9 |
| Depreciation charge | – | (165) | (165) |
| 30 September 2024 | – | 379 | 379 |
| Exchange adjustment | (8) | (1) | (9) |
| Additions | 682 | 53 | 735 |
| Depreciation charge | (52) | (169) | (221) |
| 30 September 2025 | 622 | 262 | 884 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Lease liabilities: | ||
| At start of year | 391 | 549 |
| Exchange adjustment | (7) | (4) |
| Additions | 735 | 9 |
| Lease liabilities finance expense | 34 | 13 |
| Repayments of lease liabilities | (227) | (176) |
| Balance at end of year | 926 | 391 |
| Of which: | ||
| Current lease liabilities | 205 | 172 |
| Non-current lease liabilities | 721 | 219 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Maturity analysis – undiscounted lease payments: | ||
| Within one year | 175 | 172 |
| In one to two years | 180 | 118 |
| In two to five years | 300 | 121 |
| In more than five years | 365 | – |
| Parent Company | £’000 |
| Cost: | |
| 1 October 2023 | 38,574 |
| Capital contribution to subsidiaries | 492 |
| 30 September 2024 | 39,066 |
| Capital contribution to subsidiaries | 292 |
| 30 September 2025 | 39,358 |
| Parent Company | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Subsidiary: | ||
| R.C. Treatt & Co Limited – 100% (2024: 100%) | 29,499 | 29,228 |
| Treatt USA Inc – 100% (2024: 100%) | 9,418 | 9,397 |
| Treatt Trading (Shanghai) Company Limited – 100% (2024: 100%) | 441 | 441 |
| 39,358 | 39,066 |
| Subsidiary | ||
| Country of | ||
| incorporation Holding Principal activity | ||
| Wholly-owned by Treatt PLC: | ||
| R.C. Treatt & Co Limited | England | |
| 1 | ||
| 100% Supply of flavour and fragrance ingredients | ||
| Treatt USA Inc | USA | |
| 2 | ||
| 100% Supply of flavour and fragrance ingredients | ||
| Treatt Trading (Shanghai) Company Limited | China³ | 100% Supply of flavour and fragrance ingredients |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| (restated) | ||
| 1 | ||
| £’000 | ||
| Raw materials | 25,032 | 19,265 |
| Work in progress and intermediate products | 26,171 | 22,403 |
| Finished goods | 11, 321 | 13,227 |
| 62,524 | 54,895 |
| Group | Parent Company | |||
| Current | ||||
| 2025 | ||||
| £’000 | ||||
| 2024 | ||||
| (restated) | ||||
| 1 | ||||
| £’000 | ||||
| 2025 | ||||
| £’000 | ||||
| 2024 | ||||
| £’000 | ||||
| Trade receivables | ||||
| 2 | ||||
| 24,390 | 30,472 | – | – | |
| Amounts owed by subsidiaries | – | – | – | 5,258 |
| Other receivables | 522 | 605 | 43 | 42 |
| Prepayments | 1,914 | 2,030 | – | – |
| 26,826 | 33,107 | 43 | 5,300 | |
| Non-current | ||||
| Amounts owed by subsidiaries | – | – | 20,808 | – |
| – | – | 20,808 | – |
| Group | 2025 | |
| 2024 | ||
| (restated) | ||
| 1 | ||
| Average debtor days | 76 | 73 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Impairment provision: | ||
| At start of year | 125 | 216 |
| Released in year | (123) | (174) |
| Provided in year | 112 | 84 |
| Foreign exchange | 1 | (1) |
| Balance at end of year | 115 | 125 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Number of days past the due date: | ||
| 1–30 | – | – |
| 31–60 | – | – |
| Over 60 | 115 | 125 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| (restated) | ||
| 1 | ||
| £’000 | ||
| US Dollar | 25,039 | 25,158 |
| Euro | 1,657 | 2,564 |
| Chinese Yuan | 698 | 184 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| UK asset-based lending facility | 4,612 | 352 |
| US line of credit | 1,895 | 1,782 |
| China revolving credit facility | 211 | – |
| 6,718 | 2,134 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| In one year or less | 6,718 | 2,134 |
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Onerous contract provision: | ||
| At start of year | 245 | 102 |
| Utilised in year | (243) | (10 0) |
| Additional provision in year | 166 | 249 |
| Foreign exchange | 1 | (6) |
| Balance at end of year | 169 | 245 |
| Group | Parent Company | |||
| Current | ||||
| 2025 | ||||
| £’000 | ||||
| 2024 | ||||
| £’000 | ||||
| 2025 | ||||
| £’000 | ||||
| 2024 | ||||
| £’000 | ||||
| Trade payables | 16,785 | 14,241 | 259 | 66 |
| Amounts due to subsidiary undertakings | – | – | 20,539 | – |
| Other taxes and social security costs | 351 | 315 | – | – |
| Accruals and other creditors | 4,679 | 4,139 | 546 | 508 |
| 21,815 | 18,695 | 21,344 | 574 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| US Dollar | 16,449 | 12,817 |
| Euro | 643 | 215 |
| Chinese Yuan | 147 | 210 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| UK deferred tax liability | (1,930) | (2,823) |
| Overseas deferred tax liability | (2,234) | (2,225) |
| Deferred tax liabilities | (4,164) | (5,048) |
| UK deferred tax | Overseas deferred tax | |||||||
| Group | ||||||||
| Post-employment | ||||||||
| benets | ||||||||
| £’000 | ||||||||
| Fixed assets | ||||||||
| £’000 | ||||||||
| Cash fiow hedge | ||||||||
| £’000 | ||||||||
| Other and share- | ||||||||
| based payments | ||||||||
| £’000 | ||||||||
| Losses | ||||||||
| £’000 | ||||||||
| Fixed assets | ||||||||
| £’000 | ||||||||
| Other temporary | ||||||||
| differences | ||||||||
| £’000 | ||||||||
| Total | ||||||||
| £’000 | ||||||||
| 1 October 2023 | (931) | (3,665) | 27 | 232 | 2,690 | (3,901) | 697 | (4,851) |
| Credit/(charge) to income statement: | ||||||||
| For the year | (141) | (678) | – | (92) | 423 | 84 | 524 | 120 |
| In respect of prior period | – | (64) | – | 28 | – | 37 | – | 1 |
| For change in tax rate | – | – | – | – | – | 77 | – | 77 |
| Credit/(charge) to other comprehensive income: | ||||||||
| For the year | (323) | – | (49) | – | (257) | – | – | (629) |
| Credit to equity: | ||||||||
| For the year | – | – | – | (23) | – | – | – | (23) |
| Foreign exchange differences | – | – | – | – | – | 257 | – | 257 |
| 1 October 2024 | (1,395) | (4,407) | (22) | 145 | 2,856 | (3,446) | 1,221 | (5,048) |
| Credit/(charge) to income statement: | ||||||||
| For the year | (39) | 93 | – | (56) | 124 | 111 | (91) | 142 |
| In respect of prior period | – | 141 | – | (93) | 277 | (47) | – | 278 |
| Credit/(charge) to other comprehensive income: | ||||||||
| For the year | 419 | – | 27 | – | – | 12 | (2) | 456 |
| Foreign exchange differences | – | – | – | – | – | 11 | (3) | 8 |
| 30 September 2025 | (1,015) | (4,173) | 5 | (4) | 3,257 | (3,359) | 1,125 | (4,164) |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Current: | ||
| Derivative financial assets | 81 | 380 |
| Derivative financial liabilities | (63) | – |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Income statement: | ||
| Foreign exchange contracts | 3 | 808 |
| Other comprehensive income: | ||
| Foreign exchange contracts | (109) | 195 |
| Parent Company and Group – | ||||
| Authorised, called up, allotted and fully paid | ||||
| 2025 | 2024 | |||
| £’000 | Number | £’000 | Number | |
| At start of year | 1,225 | 61,209,761 | 1,223 | 61,129,589 |
| Issued in year | 1 | 73,332 | 2 | 80,172 |
| At end of year | 1,226 | 61,283,093 | 1,225 | 61,209,761 |
| Parent Company and Group – | ||
| Authorised, called up, allotted and fully paid | ||
| 2025 | ||
| £’000 | Number | |
| At start of year | – | – |
| Issued in year | 39 | 1,94 0,161 |
| At end of year | 39 | 1,9 4 0,161 |
| Parent Company and Group | £’000 |
| Balance at 1 October 2024 and 30 September 2025 | 23,484 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Share option schemes – see (a) below | 4 | 113 |
| Share incentive plans – see (b) below | 288 | 379 |
| 292 | 492 | |
| Effect of movement in foreign exchange rates | – | 20 |
| 292 | 512 |
| Number of share | ||||
| options outstanding | ||||
| at 30 September | ||||
| 2025 | ||||
| Number | ||||
| exercised | ||||
| in year | ||||
| Exercise price | ||||
| per share | ||||
| Date option | ||||
| exercisable | ||||
| UK SAYE¹ Scheme 2023 | 42,670 | – | 566.0 | Sep 2026 – Feb 2027 |
| UK SAYE¹ Scheme 2024 | 118 , 9 5 0 | – | 371.0 | Sep 2027 – Feb 2028 |
| UK SAYE¹ Scheme 2025 | 186,793 | – | 212.0 | Sep 2028 – Feb 2029 |
| US ESPP | ||||
| 2 | ||||
| Scheme 2024 | – | – | 394.2 | July 2025 |
| US ESPP | ||||
| 2 | ||||
| Scheme 2025 | 22,276 | – | 248.0 | July 2026 |
| UK LTIP³ Scheme 2016 | 2,735 | – | – | Jun 2019 – Jun 2026 |
| UK LTIP³ Scheme 2017 | 974 | – | – | Jun 2020 – Jun 2027 |
| UK LTIP³ Scheme 2019 | 7,190 | – | – | Jun 2022 – Jun 2029 |
| UK LTIP³ Scheme 2020 | 5,255 | – | – | Jun 2023 – Jun 2030 |
| UK LTIP³ Scheme 2021 | 1,234 | – | – | Jun 2024 – Jun 2031 |
| UK LTIP³ Scheme 2022 | 11,521 | – | – | Dec 2025 – Dec 2032 |
| US LTIP³ Scheme 2022 | 36,028 | – | – | Jun 2025 – Feb 2026 |
| UK LTIP³ Scheme 2023 | 49,003 | – | – | Dec 2026 – Dec 2033 |
| US LTIP³ Scheme 2023 | 19,681 | – | – | Dec 2026 – Dec 2033 |
| UK LTIP³ Scheme 2024 | 41,926 | – | – | Dec 2027 – Dec 2034 |
| US LTIP³ Scheme 2024 | 16,734 | – | – | Dec 2027 – Dec 2034 |
| UK Executive | ||||
| 4 | ||||
| Options 2018 | – | 29,941 | – | Dec 2021 – Dec 2028 |
| UK Executive | ||||
| 4 | ||||
| Options 2019 | – | 34,987 | – | Dec 2022 – Dec 2029 |
| UK Executive | ||||
| 4 | ||||
| Options 2020 | – | 9,274 | – | Dec 2023 – Dec 2030 |
| UK Executive | ||||
| 4 | ||||
| Options 2022 | – | – | – | Dec 2025 – Dec 2032 |
| UK Executive | ||||
| 4 | ||||
| Options 2023 | – | – | – | Dec 2026 – Dec 2033 |
| UK Executive | ||||
| 4 | ||||
| Options 2024 | 137,987 | – | – | Dec 2027 – Dec 2034 |
| All-employee share schemes: | ||||
| US ESPP | ||||
| 2025 | ||||
| SAYE | ||||
| 2025 | ||||
| US ESPP | ||||
| 2024 | ||||
| SAYE | ||||
| 2024 | ||||
| Share price at date of grant | 265.0p | 265.0p | 463.8p | 463.8p |
| Contractual life | 1.0 years | 3.5 years | 1.0 years | 3.5 years |
| Expected life | 1.0 years | 3.1 years | 1.0 years | 3.1 years |
| Expected volatility | 65.9% | 54.5% | 37.3% | 46.2% |
| Risk-free interest rate | 3.8% | 3.9% | 4.4% | 3.9% |
| Dividend yield | 3.2% | 3.2% | 1.7% | 1.7% |
| Expected cancellations | 10.0% | 10.0% | 10.0% | 10.0% |
| Expected forfeitures | 15.0% | 20.0% | 10.0% | 15.0% |
| Fair value per option at date of grant | 74.6p | 96.4p | 97.4p | 164.7p |
| Key-employee share schemes: | |||||
| UK LTIP | |||||
| 2024 | |||||
| US LTIP | |||||
| 2024 | |||||
| UK Exec | |||||
| 2024 | |||||
| UK LTIP | |||||
| 2023 | |||||
| UK Exec | |||||
| 2023 | |||||
| Share price at date of grant | 462.0p | 462.0p | 462.0p | 418.0p | 418.0 p |
| Contractual life | 10.0 years | 10.0 years | 10.0 years | 10.0 years | 10.0 years |
| Expected life | 3.2 years | 3.2 years | 3.2 years | 3.2 years | 3.2 years |
| Expected volatility | 49.0% | 49.0% | 45.0% | 46.0% | 46.0% |
| Risk-free interest rate | 4.5% | 4.5% | 4.5% | 4.5% | 4.5% |
| Dividend yield | 1.7% | 1.7% | 1.7% | 1.8% | 1.8% |
| Expected cancellations | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Expected forfeitures | 99.0% | 98.0% | 99.0% | 100% | 100% |
| Fair value per option at date of grant | 436.9p | 436.9p | 436.9p | 415.1p | 415.1p |
| 2025 | 2024 | |||
| All share schemes | ||||
| Number | ||||
| of options | ||||
| Weighted | ||||
| average exercise | ||||
| price | ||||
| Number | ||||
| of options | ||||
| Weighted average | ||||
| exercise price | ||||
| Outstanding at start of year | 759,127 | £1.67 | 751,745 | £2.06 |
| Granted during the year | 530,364 | £0.77 | 413,544 | £1.38 |
| Forfeited during the year | (434,297) | £0.40 | (284,721) | £0.94 |
| Exercised during the year | (74,202) | – | (47,418) | £ 0 .11 |
| Lapsed during the year | (57,623) | £5.45 | (24,097) | £7.37 |
| Cancelled during the year | (22,428) | £1.08 | (49,926) | £10.82 |
| Outstanding at end of year | 700,941 | £1.54 | 759,127 | £1.67 |
| Exercisable at end of year | 53,400 | £1.54 | 9 9 , 911 | £1.24 |
| Number of free and matching | ||||
| shares | Number of nil cost RSUs | |||
| Group | 2025 | 2024 | 2025 | 2024 |
| Outstanding at start of year | 111,328 | 105,750 | 33,450 | 24,498 |
| Granted during the year | 50,123 | 6 2 , 611 | 15,219 | 18,624 |
| Vested during the year | (32,066) | (43,876) | (4,883) | (6,306) |
| Forfeited during the year | (2,740) | (6,915) | (7,087) | (3,276) |
| Released during the year | (5,628) | (6,242) | (316) | (90) |
| Outstanding at end of year | 121,017 | 111,328 | 36,383 | 33,450 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Defined contribution schemes | 1,201 | 1,213 |
| Other pension costs | – | – |
| 1,201 | 1,213 |
| Group | 2025 | 2024 |
| Discount rate | 5.75% | 5.20% |
| Rate of inflation (RPI) | 3.20% | 3.25% |
| Rate of inflation (CPI) | 2.75% | 2.75% |
| Rate of increase in pensions in payment – CPI max 5% | 2.70% | 2.70% |
| Rate of increase in pensions in payment – CPI max 3% | 2.20% | 2.20% |
| Rate of increase in pensions in payment – CPI max 2.5% | 1.95% | 1.95% |
| Commutation allowance | 20.0% | 20.0% |
| Proportion married (at retirement or earlierdeath) | 75.0% | 75.0% |
| GMP equalisation allowance | 0.46% of liability value | 0.46% of liability value |
| Rate of increase in salaries | N/A | N/A |
| Mortality table | S3PA tables with | |
| CMI 2023 projections | ||
| 1 | ||
| S3PA tables with | ||
| CMI 2023 projections | ||
| 1 | ||
| Life expectancy for maleaged 65 in 20 years’ time | 23.1 | 23.0 |
| Life expectancy for female aged 65 in 20 years’ time | 25.7 | 25.6 |
| Life expectancy for maleaged 65 now | 21.7 | 21.7 |
| Life expectancy for female aged 65 now | 24.3 | 24.2 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Scheme assets: | ||
| Bonds | 19,882 | 5 , 011 |
| Cash | 402 | 1,489 |
| Equities | – | 3,462 |
| Gilts | – | 11, 3 9 0 |
| Multi-asset credit | – | 1,464 |
| Fair value of scheme assets | 20,284 | 22,816 |
| Present value of funded obligations (scheme liabilities) | (16,224) | (17,238) |
| Surplus in the scheme recognised in the balance sheet | 4,060 | 5,578 |
| Related deferred tax | (1,015) | (1,395) |
| Net pension surplus | 3,045 | 4,183 |
| Changes in scheme liabilities: | ||
| Balance at start of year | (17, 238) | (16,736) |
| Interest cost | (874) | (939) |
| Benefits paid | 868 | 811 |
| Remeasurement (losses)/gains: | ||
| – Experience (loss)/gain on liabilities | (34) | 210 |
| – Gain from changes to demographic assumptions | – | 237 |
| – Actuarial gain/(loss) arising from changes in financial assumptions | 1,054 | (821) |
| Balance at end of year | (16,224) | (17, 238) |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Changes in scheme assets: | ||
| Balance at start of period | 22,816 | 20,459 |
| Interest on scheme assets | 1,161 | 1,163 |
| Employer contributions | – | 337 |
| Benefits paid | (868) | (811) |
| Administration costs | (129) | – |
| Remeasurement (losses)/gains: | ||
| – Return on plan assets (excluding amounts included in interest expense) | (2,696) | 1,668 |
| Balance at end of year | 20,284 | 22,816 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Amount charged to nance costs: | ||
| Interest on scheme assets | 1,161 | 1,163 |
| Interest on scheme liabilities | (874) | (939) |
| Net income recognised in income statement | 287 | 224 |
| Amount recognised in statement of comprehensive income: | ||
| (Loss)/gain on scheme assets in excess of interest | (2,696) | 1,668 |
| Experience (loss)/gain on liabilities | (34) | 210 |
| Gain from changes to demographic assumptions | – | 237 |
| Actuarial gain/(loss) from changes to financial assumptions | 1,054 | (821) |
| Remeasurement (loss)/gain recognised in statement of comprehensive | ||
| income | (1,676) | 1,294 |
| Actual return on scheme assets | (1,535) | 2,831 |
| Cumulative remeasurement gain recognised in statement of | ||
| comprehensive income | 1,101 | 2,777 |
| Reduce | |
| surplus by: | |
| £’000 | |
| Reduce discount rate by 0.25% p.a. | 461 |
| Increase inflation and all related assumptions by 0.1% p.a. | 103 |
| Increase life expectancy by one year | 455 |
| Group | Parent Company | |||
| 2025 | ||||
| £’000 | ||||
| 2024 | ||||
| (restated) | ||||
| 1 | ||||
| £’000 | ||||
| 2025 | ||||
| £’000 | ||||
| 2024 | ||||
| £’000 | ||||
| Financial assets | ||||
| Measured at amortised cost: | ||||
| Trade receivables | ||||
| 2 | ||||
| 24,390 | 27,755 | – | – | |
| Other receivables | 522 | 605 | 43 | 42 |
| Cash and cash equivalents | 1,745 | 1,786 | 350 | 407 |
| Amounts owed by subsidiaries | – | – | 20,808 | 5,258 |
| Financial instruments measured at | ||||
| fair value through other comprehensive income: | ||||
| Trade receivables | ||||
| 3 | ||||
| (level 3) | 2 | 2,717 | – | – |
| Derivative nancial instruments measured | ||||
| at fair value through prot and loss: | ||||
| Forward currency contracts (level 2) | 81 | 380 | – | – |
| 26,74 0 | 33,243 | 21,201 | 5,707 |
| Group | Parent Company | |||
| 2025 | ||||
| £’000 | ||||
| 2024 | ||||
| £’000 | ||||
| 2025 | ||||
| £’000 | ||||
| 2024 | ||||
| £’000 | ||||
| Financial liabilities | ||||
| Measured at amortised cost: | ||||
| Trade payables | 16,785 | 14, 241 | 259 | 66 |
| Amounts owed to subsidiary undertakings | – | – | 20,539 | – |
| Accruals and other creditors | 4,679 | 4,139 | 546 | 508 |
| UK asset-based lending facility | 4,612 | 352 | – | – |
| US line of credit | 1,895 | 1,782 | – | – |
| Lease liabilities | 926 | 391 | – | – |
| Derivative nancial instruments measured | ||||
| at fair value through prot and loss: | ||||
| Financial derivatives – foreign exchange | 63 | – | – | – |
| 28,960 | 20,905 | 21,344 | 574 |
| Group | |||||
| Within | |||||
| 0 to 3 | |||||
| months | |||||
| £’000 | |||||
| Within | |||||
| 3 to 12 | |||||
| months | |||||
| £’000 | |||||
| Within | |||||
| 1 to 2 years | |||||
| £’000 | |||||
| Within | |||||
| 2 to 5 years | |||||
| £’000 | |||||
| Over | |||||
| 5 years | |||||
| £’000 | |||||
| Non-derivative nancial | |||||
| instruments: | |||||
| Trade payables | 16,242 | 543 | – | – | – |
| Accruals and other creditors | 4,435 | 244 | – | – | – |
| UK asset-based lending facility | 4,612 | – | – | – | – |
| US line of credit | 1,895 | – | – | – | – |
| Derivative nancial instruments: | |||||
| Forward currency contracts | 21 | 42 | – | – | – |
| Group | ||||
| Floating rate | ||||
| nancial assets/(liabilities) | ||||
| Fixed rate | ||||
| nancial liabilities | ||||
| 2025 | ||||
| £’000 | ||||
| 2024 | ||||
| £’000 | ||||
| 2025 | ||||
| £’000 | ||||
| 2024 | ||||
| £’000 | ||||
| Bank balances and revolving credit | ||||
| facilities: | ||||
| Sterling | 560 | 947 | – | – |
| US Dollars | (1,135) | (1,621) | – | – |
| Euro | 335 | 4 | – | – |
| Chinese Yuan | (121) | 674 | – | – |
| Asset-based lending facility: | ||||
| Sterling | (4,612) | (15) | – | – |
| Euro | – | (337) | – | – |
| Lease liabilities: | ||||
| Sterling | – | – | (926) | (391) |
| Total net debt | (4,973) | (348) | (926) | (391) |
| Group | Parent Company | |||
| 2025 | ||||
| £’000 | ||||
| 2024 | ||||
| £’000 | ||||
| 2025 | ||||
| £’000 | ||||
| 2024 | ||||
| £’000 | ||||
| Impact on profit before tax of 100bps interest | ||||
| ratemovement | (40) | (10 0) | – | – |
| Group – as at 30 September 2025 | ||||
| Average | ||||
| contract | ||||
| rate | ||||
| Nominal | ||||
| currency | ||||
| ’000 | ||||
| Contract | ||||
| GBP | ||||
| £’000 | ||||
| Fair value | ||||
| gain/(loss) | ||||
| £’000 | ||||
| US Dollars: | ||||
| Forward contracts to buy USD within 1–3 months | 1.3617 | $1,000 | 734 | 9 |
| Forward contracts to sell USD within 1–3 months | 1.3181 | $3,500 | 2,646 | 44 |
| Forward contracts to sell USD within 3–6 months | 1.2785 | $900 | 704 | 17 |
| Forward contracts to sell USD within 6–9 months | 1.3527 | $2,000 | 1,479 | (9) |
| Forward contracts to sell USD within 9–12 months | 1.3524 | $600 | 444 | (3) |
| Euros: | ||||
| Forward contracts to sell EUR within 1–3 months | 1.1691 | € 711 | 608 | (10) |
| Forward contracts to sell EUR within 3–6 months | 1.1782 | €625 | 530 | (20) |
| Forward contracts to sell EUR within 6–9 months | 1.1556 | €600 | 521 | (8) |
| Forward contracts to sell EUR within 9–12 months | 1.1377 | €300 | 264 | (2) |
| 18 |
| Group – as at 30 September 2024 | ||||
| Average | ||||
| contract rate | ||||
| Nominal | ||||
| currency | ||||
| ’000 | ||||
| Contract | ||||
| GBP | ||||
| £’000 | ||||
| Fair value | ||||
| gain/(loss) | ||||
| £’000 | ||||
| US Dollars: | ||||
| Forward contracts to sell USD within 1–3 months | 1.2711 | $990 | 779 | 40 |
| Forward contracts to sell USD within 3–6 months | 1.2669 | $4,150 | 3,276 | 229 |
| Forward contracts to sell USD within 6–9 months | 1.2888 | $3,10 0 | 2,395 | 90 |
| Euros: | ||||
| Forward contracts to sell EUR within 1–3 months | 1.1732 | €1,150 | 979 | 14 |
| Forward contracts to sell EUR within 3–6 months | 1.1749 | €750 | 638 | 6 |
| Forward contracts to sell EUR within 6–9 months | 1.1724 | €250 | 213 | 1 |
| 380 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Revenue | 3 | 808 |
| Other comprehensive income | (109) | 195 |
| (106) | 1,003 |
| Group | |
| Hedging | |
| reserve | |
| £’000 | |
| 1 October 2023 | (42) |
| Fair value movement on: | |
| Cash flow hedges of probable future receipts | (613) |
| Transfer from hedging reserve to prot and loss account | 808 |
| Amounts recognised in other comprehensive income | 195 |
| Taxation relating to items above | (49) |
| 30 September 2024 | 104 |
| Fair value movement on: | |
| Cash flow hedges of probable future receipts | (112) |
| Transfer from hedging reserve to prot and loss account | 3 |
| Amounts recognised in other comprehensive income | (109) |
| Taxation relating to items above | 27 |
| 30 September 2025 | 22 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| (restated) | ||
| 1 | ||
| £’000 | ||
| Net foreign currency nancial assets: | ||
| US Dollar | 4,346 | 5,239 |
| Euro | 1,487 | 2,146 |
| Chinese Yuan | 430 | 653 |
| 6,263 | 8,038 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| (restated) | ||
| 1 | ||
| £’000 | ||
| Impact of 10% strengthening of US Dollar against Sterling | 483 | 582 |
| Impact of 10% strengthening of Euro against Sterling | 165 | 238 |
| Group | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Salaries and other short-term employee benefits | 767 | 699 |
| Fees paid to Non-executive Directors in respect of qualifying services | 354 | 367 |
| Employer’s social security costs | 154 | 137 |
| Pension contributions to money purchase schemes | 59 | 51 |
| Share-based payments expense in respect of qualifying services | – | 69 |
| 1,334 | 1,323 |
| Parent Company | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Interest received/(paid) from/(to): | ||
| R.C. Treatt & Co Limited | 666 | 340 |
| Treatt USA Inc | (404) | – |
| Dividends received from: | ||
| R.C. Treatt & Co Limited | 472 | 284 |
| Treatt USA Inc | 4,675 | 4,640 |
| Parent Company | ||
| 2025 | ||
| £’000 | ||
| 2024 | ||
| £’000 | ||
| Amounts owed to/(from) Parent Company: | ||
| R.C. Treatt & Co Limited | 20,808 | 5,245 |
| Treatt USA Inc | (20,539) | 13 |
| 269 | 5,258 |
| Group | |||
| Previously | |||
| reported | |||
| £’000 | |||
| Adjustment | |||
| £’000 | |||
| As | |||
| restated | |||
| £’000 | |||
| Revenue | 153,066 | (2,863) | 150,203 |
| Cost of sales | (108,580) | 2,319 | (106,261) |
| Gross profit | |||
| 1 | |||
| 44,486 | (544) | 43,942 | |
| Profit before taxation | |||
| 1 | |||
| 19,093 | (544) | 18,549 | |
| Basic earnings per share (pence) | 23.61p | (0.90p) | 22.71p |
| Diluted earnings per share (pence) | 23.48p | (0.89p) | 22.59p |
| Group | |||
| Previously | |||
| reported | |||
| £’000 | |||
| Adjustment | |||
| £’000 | |||
| As | |||
| restated | |||
| £’000 | |||
| Inventories | 51,878 | 3,017 | 54,895 |
| Trade and other receivables | 37,078 | (3,971) | 33,107 |
| Retained earnings | 116 ,153 | (954) | 115 ,19 9 |
| Cash flow statement impact: decrease in inventories | 7,231 | (2,396) | 4,835 |
| Cash flow statement impact: increase in receivables | (5,651) | 2,940 | (2 ,711) |
| Group | |||
| Previously | |||
| reported | |||
| £’000 | |||
| Adjustment | |||
| £’000 | |||
| As | |||
| restated | |||
| £’000 | |||
| Inventories | 62,396 | 698 | 63,094 |
| Trade and other receivables | 32,969 | (1,108) | 31,861 |
| Retained earnings | 105,120 | (410) | 104,710 |
| Group | ||||
| Page | ||||
| reference | ||||
| 2025 | ||||
| £’000 | ||||
| 2024 | ||||
| (restated) | ||||
| 1 | ||||
| £’000 | ||||
| 2023 | ||||
| (restated) | ||||
| 1 | ||||
| £’000 | ||||
| Total equity | 112 | 134,739 | 141,060 | 136,836 |
| Net debt | 115 | 5,899 | 739 | 10,382 |
| Capital employed | 140,638 | 141,799 | 147,218 | |
| Interim total equity | ||||
| 2 | ||||
| 143,137 | 137,647 | 129,6 85 | ||
| Interim net (cash)/debt | ||||
| 2 | ||||
| (949) | 10,345 | 17,704 | ||
| Interim capital employed | ||||
| 2 | ||||
| 142,18 8 | 147,992 | 147, 389 | ||
| Average capital employed | ||||
| 3 | ||||
| 141,542 | 145,670 | 150,292 | ||
| Adjusted operating prot | ||||
| 4 | ||||
| 107 | 10,666 | 19,325 | 17, 911 | |
| ROACE % | 7.5% | 13.3% | 11. 9 % |
| Group | Page reference | ||
| 2025 | |||
| £’000 | |||
| 2024 | |||
| (restated) | |||
| 1 | |||
| £’000 | |||
| Average capital employed | |||
| 2 | |||
| 141,542 | 145,670 | ||
| Profit before taxation | 107 | 7,003 | 17, 919 |
| ROACE % | 4.9% | 12.3% |
| Group | |||
| Page | |||
| reference | |||
| 2025 | |||
| £’000 | |||
| 2024 | |||
| (restated) | |||
| 1 | |||
| £’000 | |||
| Profit before taxation | 107 | 7,003 | 17, 919 |
| Exceptional items | 107 | 3,309 | 630 |
| Prot before taxation and exceptional items | 107 | 10,312 | 18,549 |
| Interest receivable | 107 | (290) | (229) |
| Interest payable | 107 | 644 | 1,005 |
| Depreciation of property, plant and equipment and right-of-use assets | 113 | 5,039 | 4,640 |
| Amortisation of intangible assets | 113 | 469 | 426 |
| Adjusted EBITDA | 16,174 | 24,391 | |
| Net debt | 115 | 5,899 | 739 |
| Net debt to adjusted EBITDA | 0.36 | 0.03 |
| Group | |||
| Page | |||
| reference | |||
| 2025 | |||
| £’000 | |||
| 2024 | |||
| (restated) | |||
| 1 | |||
| £’000 | |||
| Profit before taxation | 107 | 7,003 | 17,919 |
| Interest receivable | 107 | (290) | (229) |
| Interest payable | 107 | 644 | 1,005 |
| Depreciation of property, plant and equipment and right-of-use assets | 113 | 5,039 | 4,640 |
| Amortisation of intangible assets | 113 | 469 | 426 |
| EBITDA | 12,865 | 23,761 | |
| Net debt | 115 | 5,899 | 739 |
| Net debt to EBITDA | 0.46 | 0.03 |